Oral health-related quality of life: what, why, how, and future implications
L Sischo, HL Broder - Journal of dental research, 2011 - journals.sagepub.com
Despite its relatively recent emergence over the past few decades, oral health-related
quality of life (OHRQoL) has important implications for the clinical practice of dentistry and …
quality of life (OHRQoL) has important implications for the clinical practice of dentistry and …
A point of minimal important difference (MID): a critique of terminology and methods
MT King - Expert review of pharmacoeconomics & outcomes …, 2011 - Taylor & Francis
The minimal important difference (MID) is a phrase with instant appeal in a field struggling to
interpret health-related quality of life and other patient-reported outcomes. The terminology …
interpret health-related quality of life and other patient-reported outcomes. The terminology …
[HTML][HTML] FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer
T Conroy, F Desseigne, M Ychou… - New England journal …, 2011 - Mass Medical Soc
Background Data are lacking on the efficacy and safety of a combination chemotherapy
regimen consisting of oxaliplatin, irinotecan, fluorouracil, and leucovorin (FOLFIRINOX) as …
regimen consisting of oxaliplatin, irinotecan, fluorouracil, and leucovorin (FOLFIRINOX) as …
[HTML][HTML] Sunitinib malate for the treatment of pancreatic neuroendocrine tumors
Background The multitargeted tyrosine kinase inhibitor sunitinib has shown activity against
pancreatic neuroendocrine tumors in preclinical models and phase 1 and 2 trials. Methods …
pancreatic neuroendocrine tumors in preclinical models and phase 1 and 2 trials. Methods …
Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer …
KJ Yost, DT Eton, SF Garcia, D Cella - Journal of clinical epidemiology, 2011 - Elsevier
Objective We combined anchor-and distribution-based methods to establish minimally
important differences (MIDs) for six Patient-Reported Outcomes Measurement Information …
important differences (MIDs) for six Patient-Reported Outcomes Measurement Information …
[HTML][HTML] Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled …
CM Nutting, JP Morden, KJ Harrington… - The lancet …, 2011 - thelancet.com
Background Xerostomia is the most common late side-effect of radiotherapy to the head and
neck. Compared with conventional radiotherapy, intensity-modulated radiotherapy (IMRT) …
neck. Compared with conventional radiotherapy, intensity-modulated radiotherapy (IMRT) …
[PDF][PDF] Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality …
K Cocks, MT King, G Velikova… - Journal of Clinical …, 2011 - Citeseer
Evidence-Based Guidelines for Determination of Sample Size and Interpretation of the
European Organisation for the Research and Page 1 Evidence-Based Guidelines for …
European Organisation for the Research and Page 1 Evidence-Based Guidelines for …
70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial
V Beckendorf, S Guerif, E Le Prisé, JM Cosset… - International Journal of …, 2011 - Elsevier
PURPOSE: To perform a randomized trial comparing 70 and 80 Gy radiotherapy for prostate
cancer. PATIENTS AND METHODS: A total of 306 patients with localized prostate cancer …
cancer. PATIENTS AND METHODS: A total of 306 patients with localized prostate cancer …
[HTML][HTML] Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non–small-cell lung cancer: neurocognitive and …
A Sun, K Bae, EM Gore, B Movsas… - Journal of clinical …, 2011 - ncbi.nlm.nih.gov
Purpose There are scant data regarding the effects of prophylactic cranial irradiation (PCI)
on neurocognitive function (NCF) and quality of life (QOL). Radiation Therapy Oncology …
on neurocognitive function (NCF) and quality of life (QOL). Radiation Therapy Oncology …
[HTML][HTML] Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and …
Background This review aims to assist cancer clinical researchers in choosing between the
two most widely used measures of cancer-specific health-related quality of life: the …
two most widely used measures of cancer-specific health-related quality of life: the …